Literature DB >> 18803910

Use of animal models to develop antiaddiction medications.

Eliot L Gardner1.   

Abstract

Although addiction is a uniquely human phenomenon, some of its pathognomonic features can be modeled at the animal level. Such features include the euphoric "high" produced by acute administration of addictive drugs; the dysphoric "crash" produced by acute withdrawal; drug-seeking and drug-taking behaviors; and relapse to drug-seeking behavior after achieving successful abstinence. Animal models exist for each of these features. In this review, I focus on various animal models of addiction and how they can be used to search for clinically effective antiaddiction medications. I conclude by noting some of the new and novel medications that have been developed preclinically using such models and the hope for further developments along such lines.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18803910      PMCID: PMC2635567          DOI: 10.1007/s11920-008-0061-y

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  42 in total

Review 1.  What we have learned about addiction from animal models of drug self-administration.

Authors:  E L Gardner
Journal:  Am J Addict       Date:  2000

2.  Conditioned fear stimuli reinstate cocaine-induced conditioned place preference.

Authors:  C J Sanchez; B A Sorg
Journal:  Brain Res       Date:  2001-07-20       Impact factor: 3.252

3.  Neural correlates of high and craving during cocaine self-administration using BOLD fMRI.

Authors:  Robert C Risinger; Betty Jo Salmeron; Thomas J Ross; Shelley L Amen; Michael Sanfilipo; Raymond G Hoffmann; Alan S Bloom; Hugh Garavan; Elliot A Stein
Journal:  Neuroimage       Date:  2005-07-15       Impact factor: 6.556

4.  Slow-onset, long-duration 3-(3',4'-dichlorophenyl)-1-indanamine monoamine reuptake blockers as potential medications to treat cocaine abuse.

Authors:  M Froimowitz; K M Wu; A Moussa; R M Haidar; J Jurayj; C George; E L Gardner
Journal:  J Med Chem       Date:  2000-12-28       Impact factor: 7.446

5.  GABAergic blockade of cocaine-associated cue-induced increases in nucleus accumbens dopamine.

Authors:  M R Gerasimov; W K Schiffer; E L Gardner; D A Marsteller; I C Lennon; S J Taylor; J D Brodie; C R Ashby; S L Dewey
Journal:  Eur J Pharmacol       Date:  2001-03-02       Impact factor: 4.432

6.  Increased mesolimbic GABA concentration blocks heroin self-administration in the rat.

Authors:  Z X Xi; E A Stein
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

7.  Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli.

Authors:  H Garavan; J Pankiewicz; A Bloom; J K Cho; L Sperry; T J Ross; B J Salmeron; R Risinger; D Kelley; E A Stein
Journal:  Am J Psychiatry       Date:  2000-11       Impact factor: 18.112

8.  Reactivation of morphine conditioned place preference by drug priming: role of environmental cues and sensitization.

Authors:  Lin Lu; Nan-Jie Xu; Xin Ge; Wen Yue; Wen-Juan Su; Gang Pei; Lan Ma
Journal:  Psychopharmacology (Berl)       Date:  2001-09-14       Impact factor: 4.530

9.  Gamma-vinyl GABA inhibits cocaine-triggered reinstatement of drug-seeking behavior in rats by a non-dopaminergic mechanism.

Authors:  Xiao-Qing Peng; Xia Li; Jeremy G Gilbert; Arlene C Pak; Charles R Ashby; Jonathan D Brodie; Stephen L Dewey; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Drug Alcohol Depend       Date:  2007-12-11       Impact factor: 4.492

Review 10.  Second-order schedules of drug reinforcement in rats and monkeys: measurement of reinforcing efficacy and drug-seeking behaviour.

Authors:  B J Everitt; T W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

View more
  5 in total

Review 1.  Addiction and brain reward and antireward pathways.

Authors:  Eliot L Gardner
Journal:  Adv Psychosom Med       Date:  2011-04-19

2.  Nucleus accumbens dopamine/glutamate interaction switches modes to generate desire versus dread: D(1) alone for appetitive eating but D(1) and D(2) together for fear.

Authors:  Jocelyn M Richard; Kent C Berridge
Journal:  J Neurosci       Date:  2011-09-07       Impact factor: 6.167

3.  Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment.

Authors:  Vivek Kumar; Alessandro Bonifazi; Michael P Ellenberger; Thomas M Keck; Elie Pommier; Rana Rais; Barbara S Slusher; Eliot Gardner; Zhi-Bing You; Zheng-Xiong Xi; Amy Hauck Newman
Journal:  J Med Chem       Date:  2016-08-10       Impact factor: 7.446

4.  The selective D₃ receptor antagonist SB-277011A attenuates morphine-triggered reactivation of expression of cocaine-induced conditioned place preference.

Authors:  Onarae V Rice; Christian A Heidbreder; Eliot L Gardner; Charles D Schonhar; Charles R Ashby
Journal:  Synapse       Date:  2013-03-25       Impact factor: 2.562

5.  Glutamatergic targets for enhancing extinction learning in drug addiction.

Authors:  R M Cleva; J T Gass; J J Widholm; M F Olive
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.